{"result": {"id": "c3ce87d1-4374-4fe1-b38c-d7045e09d68d", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>MAHINRAD S<|>PERSON<|>Researcher who studied cumulative blood pressure exposure and cognitive function\")  \n##  \n(\"entity\"<|>KURIAN S<|>PERSON<|>Researcher who studied cumulative blood pressure exposure and cognitive function\")  \n##  \n(\"entity\"<|>GARNER CR<|>PERSON<|>Researcher who studied cumulative blood pressure exposure and cognitive function\")  \n##  \n(\"entity\"<|>HAKALA JO<|>PERSON<|>Researcher who studied cardiovascular risk factors and cognitive performance\")  \n##  \n(\"entity\"<|>PAHKALA K<|>PERSON<|>Researcher who studied cardiovascular risk factors and cognitive performance\")  \n##  \n(\"entity\"<|>JUONALA M<|>PERSON<|>Researcher who studied cardiovascular risk factors and cognitive performance\")  \n##  \n(\"entity\"<|>OISHI E<|>PERSON<|>Researcher who studied blood pressure variability and dementia risk\")  \n##  \n(\"entity\"<|>OHARA T<|>PERSON<|>Researcher who studied blood pressure variability and dementia risk\")  \n##  \n(\"entity\"<|>SAKATA S<|>PERSON<|>Researcher who studied blood pressure variability and dementia risk\")  \n##  \n(\"entity\"<|>SABAYAN B<|>PERSON<|>Researcher who studied blood pressure variability and cognitive function\")  \n##  \n(\"entity\"<|>WIJSMAN LW<|>PERSON<|>Researcher who studied blood pressure variability and cognitive function\")  \n##  \n(\"entity\"<|>FOSTER-DINGLEY JC<|>PERSON<|>Researcher who studied blood pressure variability and cognitive function\")  \n##  \n(\"entity\"<|>MA Y<|>PERSON<|>Researcher who reviewed blood pressure variability and dementia\")  \n##  \n(\"entity\"<|>TULLY PJ<|>PERSON<|>Researcher who reviewed blood pressure variability and dementia\")  \n##  \n(\"entity\"<|>HOFMAN A<|>PERSON<|>Researcher who reviewed blood pressure variability and dementia\")  \n##  \n(\"entity\"<|>PETERS R<|>PERSON<|>Researcher who studied blood pressure and dementia\")  \n##  \n(\"entity\"<|>WARWICK J<|>PERSON<|>Researcher who studied blood pressure and dementia\")  \n##  \n(\"entity\"<|>ANSTEY KJ<|>PERSON<|>Researcher who studied blood pressure and dementia\")  \n##  \n(\"entity\"<|>GUPTA A<|>PERSON<|>Researcher who studied hypertension treatment and cognitive decline\")  \n##  \n(\"entity\"<|>PERDOMO S<|>PERSON<|>Researcher who studied hypertension treatment and cognitive decline\")  \n##  \n(\"entity\"<|>BILLINGER S<|>PERSON<|>Researcher who studied hypertension treatment and cognitive decline\")  \n##  \n(\"entity\"<|>HUGHES D<|>PERSON<|>Researcher who studied blood pressure lowering and dementia risk\")  \n##  \n(\"entity\"<|>JUDGE C<|>PERSON<|>Researcher who studied blood pressure lowering and dementia risk\")  \n##  \n(\"entity\"<|>MURPHY R<|>PERSON<|>Researcher who studied blood pressure lowering and dementia risk\")  \n##  \n(\"entity\"<|>DING J<|>PERSON<|>Researcher who studied antihypertensive medications and dementia risk\")  \n##  \n(\"entity\"<|>DAVIS-PLOURDE KL<|>PERSON<|>Researcher who studied antihypertensive medications and dementia risk\")  \n##  \n(\"entity\"<|>SEDAGHAT S<|>PERSON<|>Researcher who studied antihypertensive medications and dementia risk\")  \n##  \n(\"entity\"<|>FORETTE F<|>PERSON<|>Researcher involved in the Syst-Eur study on dementia prevention\")  \n##  \n(\"entity\"<|>SEUX ML<|>PERSON<|>Researcher involved in the Syst-Eur study on dementia prevention\")  \n##  \n(\"entity\"<|>STAESSEN JA<|>PERSON<|>Researcher involved in the Syst-Eur study on dementia prevention\")  \n##  \n(\"entity\"<|>ARIMA H<|>PERSON<|>Researcher who studied blood pressure lowering and bleeding risks\")  \n##  \n(\"entity\"<|>ANDERSON C<|>PERSON<|>Researcher who studied blood pressure lowering and bleeding risks\")  \n##  \n(\"entity\"<|>OMAE T<|>PERSON<|>Researcher who studied blood pressure lowering and bleeding risks\")  \n##  \n(\"entity\"<|>YANG W<|>PERSON<|>Researcher who reviewed antihypertensive drugs and cognitive function\")  \n##  \n(\"entity\"<|>LUO H<|>PERSON<|>Researcher who reviewed antihypertensive drugs and cognitive function\")  \n##  \n(\"entity\"<|>YUSUF S<|>PERSON<|>Researcher involved in the INTERHEART study on myocardial infarction risk factors\")  \n##  \n(\"entity\"<|>HAWKEN S<|>PERSON<|>Researcher involved in the INTERHEART study on myocardial infarction risk factors\")  \n##  \n(\"entity\"<|>OUNPUU S<|>PERSON<|>Researcher involved in the INTERHEART study on myocardial infarction risk factors\")  \n##  \n(\"entity\"<|>XIE X<|>PERSON<|>Researcher who studied intensive blood pressure lowering and cardiovascular outcomes\")  \n##  \n(\"entity\"<|>ATKINS E<|>PERSON<|>Researcher who studied intensive blood pressure lowering and cardiovascular outcomes\")  \n##  \n(\"entity\"<|>LV J<|>PERSON<|>Researcher who studied intensive blood pressure lowering and cardiovascular outcomes\")  \n##  \n(\"entity\"<|>LUBSEN J<|>PERSON<|>Researcher involved in the ACTION trial on nifedipine effects\")  \n##  \n(\"entity\"<|>WAGENER G<|>PERSON<|>Researcher involved in the ACTION trial on nifedipine effects\")  \n##  \n(\"entity\"<|>KIRWAN BA<|>PERSON<|>Researcher involved in the ACTION trial on nifedipine effects\")  \n##  \n(\"entity\"<|>FOX KM<|>PERSON<|>Researcher who studied perindopril's effects on cardiovascular events\")  \n##  \n(\"relationship\"<|>MAHINRAD S<|>CIRCULATION<|>Published research on blood pressure and cognitive function in Circulation<|>7\")  \n##  \n(\"relationship\"<|>HAKALA JO<|>CIRCULATION<|>Published research on cardiovascular risk factors in Circulation<|>7\")  \n##  \n(\"relationship\"<|>OISHI E<|>CIRCULATION<|>Published research on blood pressure variability in Circulation<|>7\")  \n##  \n(\"relationship\"<|>SABAYAN B<|>BMJ<|>Published research on blood pressure variability in BMJ<|>7\")  \n##  \n(\"relationship\"<|>MA Y<|>AM J HYPERTENS<|>Published review on blood pressure variability in American Journal of Hypertension<|>6\")  \n##  \n(\"relationship\"<|>PETERS R<|>NEUROLOGY<|>Published research on blood pressure and dementia in Neurology<|>7\")  \n##  \n(\"relationship\"<|>GUPTA A<|>BMJ OPEN<|>Published meta-analysis on hypertension treatment in BMJ Open<|>6\")  \n##  \n(\"relationship\"<|>HUGHES D<|>JAMA<|>Published meta-analysis on blood pressure lowering in JAMA<|>7\")  \n##  \n(\"relationship\"<|>DING J<|>LANCET NEUROL<|>Published meta-analysis on antihypertensive medications in Lancet Neurology<|>7\")  \n##  \n(\"relationship\"<|>FORETTE F<|>SYST-EUR STUDY<|>Led the Syst-Eur study on dementia prevention<|>8\")  \n##  \n(\"relationship\"<|>ARIMA H<|>PROGRESS TRIAL<|>Studied blood pressure effects in the PROGRESS trial<|>8\")  \n##  \n(\"relationship\"<|>YUSUF S<|>INTERHEART STUDY<|>Led the INTERHEART study on myocardial infarction<|>8\")  \n##  \n(\"relationship\"<|>XIE X<|>LANCET<|>Published meta-analysis on blood pressure lowering in Lancet<|>7\")  \n##  \n(\"relationship\"<|>LUBSEN J<|>ACTION TRIAL<|>Led the ACTION trial on nifedipine effects<|>8\")  \n##  \n(\"relationship\"<|>FOX KM<|>PERINDOPRIL STUDY<|>Studied perindopril's cardiovascular effects<|>7\")  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559046, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 2031, "prompt_tokens": 3622, "total_tokens": 5653, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3136}, "prompt_cache_hit_tokens": 3136, "prompt_cache_miss_tokens": 486}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: tension,2021,77(3) :972-979.\n[541]  Mahinrad S, Kurian S, Garner CR,  et al.  Cumulative blood pressureexposureduringyoung adulthoodandmobilityand cog- nitivefunction in midlife[J]. Circulation,2020,141(9) :712-724.\n[542]  Hakala JO, Pahkala K, Juonala M, et al.  Cardiovascular risk factor trajectories since childhood and cognitive performance in midlife: thecardiovascularriskinyoungFINNSstudy[J]. Circu- lation,2021,143(20) :1949-1961.\n[543]  OishiE, Ohara T, Sakata S, et al.  Day-to-day blood pressure variabilityandriskofdementiainageneraljapaneseelderlypop- ulation: the HISAYAMA study[J]. Circulation, 2017, 136(6) :  516-525.\n[544]  Sabayan B, WijsmanLW , Foster-DingleyJC, etal. Association ofvisit-to-visitvariabilityin blood pressure with cognitive func- tion in old age: prospective cohort study[J]. BMJ, 2013, 347:  f4600.\n[545]  MaY, Tully PJ, Hofman A, et al.  Blood pressure variability and dementia: a state-of-the-art review[J]. Am J Hypertens,  2020,33(12) :1059-1066.\n[546]  PetersR, WarwickJ, AnsteyKJ, etal. Bloodpressureandde- mentia: what the SPRINT-MIND trial adds and what we still need to know[J]. Neurology,2019,92(21) :1017-1018.\n[547]  GuptaA, PerdomoS, BillingerS, etal. Treatmentofhyperten- sion reduces cognitive decline in older adults: a systematic re- view and meta-analysis[J]. BMJ Open,2020,10(11) :e038971.\n[548]  Hughes D,  Judge C, Murphy R,  et al.  Association of blood pressure lowering with incident dementia or cognitive impair- ment: a systematic review and meta-analysis[J]. JAMA, 2020,  323(19) :1934-1944.\n[549]  DingJ, Davis-PlourdeKL, SedaghatS, etal. Antihypertensive medicationsand risk forincidentdementia and Alzheimer’sdis- ease: ameta-analysisofindividualparticipantdatafrom prospec- tivecohortstudies[J]. LancetNeurol,2020,19(1) :61-70.\n[550]  中国老年医学学会 , 中国老年医学学会高血压分会 , 中国老年医 学学会认知障碍分会 ,等.  老年高血压合并认知障碍诊疗中国专 家共识(2021版)[J]. 中国心血管杂志 ,2021,26(2) :101-111.\n[551]  ForetteF, SeuxML, StaessenJA, etal. Theprevention ofde- mentiawith antihypertensivetreatment: new evidence from the SystolicHypertension in Europe(Syst-Eur) study[J]. Arch In- tern Med,2002,162(18) :2046-2052.\n\n\n\n[552]  Arima H, Anderson C, OmaeT, etal.  Effects ofblood pres- sureloweringonintracranialandextracranialbleedinginpatients on antithrombotic therapy:  the PROGRESS trial[J]. Stroke,  2012,43(6) :1675-1677.\n[553]  YangW , LuoH, MaY, etal. Effectsofantihypertensivedrugs on cognitivefunctionin elderlypatientswithhypertension: are- view[J]. AgingDis,2021,12(3) :841-851.\n[554]  PetersR, YasarS, AndersonCS, etal. Investigationofantihy- pertensiveclass, dementia, and cognitivedecline: ameta-analy- sis[J]. Neurology,2020,94(3) :e267-e281.\n[555]  Yusuf S,  Hawken S,  Ounpuu S,  et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) :  case-control study [J]. Lancet,2004,364(9438) :937-952.\n[556]  XieX, AtkinsE, LvJ, etal. Effectsofintensivebloodpressure lowering on cardiovascularand renaloutcomes: updated system- aticreview andmeta-analysis[J]. Lancet,2016,387(10017) :435- 443.\n[557]  LubsenJ, WagenerG, KirwanBA, etal. Effectoflong-acting nifedipineon mortality and cardiovascular morbidity in patients with symptomaticstableanginaand hypertension: theACTION  trial[J]. J Hypertens,2005,23(3) :641-648.\n[558]  Fox KM.  Efficacy of perindoprilin reduction of cardiovascular eventsamongpatientswith\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>CIRCULATION<|>ORGANIZATION<|>A journal publishing research on cardiovascular health and related topics\")  \n##  \n(\"entity\"<|>BMJ<|>ORGANIZATION<|>A medical journal publishing research on various health topics, including cognitive function and blood pressure\")  \n##  \n(\"entity\"<|>JAMA<|>ORGANIZATION<|>A leading medical journal publishing research on hypertension and dementia\")  \n##  \n(\"entity\"<|>LANCET<|>ORGANIZATION<|>A prestigious medical journal covering research on cardiovascular diseases and risk factors\")  \n##  \n(\"entity\"<|>NEUROLOGY<|>ORGANIZATION<|>A journal publishing research on neurological conditions, including dementia\")  \n##  \n(\"entity\"<|>中国老年医学学会<|>ORGANIZATION<|>Chinese Geriatrics Society, involved in creating expert consensus on hypertension and cognitive impairment\")  \n##  \n(\"entity\"<|>SPRINT-MIND TRIAL<|>EVENT<|>A clinical trial investigating the effects of blood pressure lowering on cognitive decline\")  \n##  \n(\"entity\"<|>SYST-EUR STUDY<|>EVENT<|>A study examining the prevention of dementia with antihypertensive treatment\")  \n##  \n(\"entity\"<|>PROGRESS TRIAL<|>EVENT<|>A trial studying the effects of blood pressure lowering on bleeding risks in patients on antithrombotic therapy\")  \n##  \n(\"entity\"<|>INTERHEART STUDY<|>EVENT<|>A case-control study analyzing modifiable risk factors for myocardial infarction across 52 countries\")  \n##  \n(\"entity\"<|>ACTION TRIAL<|>EVENT<|>A trial investigating the effects of long-acting nifedipine on mortality and cardiovascular morbidity\")  \n##  \n(\"relationship\"<|>CIRCULATION<|>BMJ<|>Both journals publish research on blood pressure and cognitive function<|>4\")  \n##  \n(\"relationship\"<|>JAMA<|>LANCET<|>Both are leading medical journals publishing research on cardiovascular health<|>5\")  \n##  \n(\"relationship\"<|>SPRINT-MIND TRIAL<|>NEUROLOGY<|>The trial's findings were discussed in the journal Neurology<|>6\")  \n##  \n(\"relationship\"<|>SYST-EUR STUDY<|>LANCET<|>The study was published in the Lancet<|>7\")  \n##  \n(\"relationship\"<|>PROGRESS TRIAL<|>STROKE<|>The trial's results were published in the journal Stroke<|>6\")  \n##  \n(\"relationship\"<|>INTERHEART STUDY<|>LANCET<|>The study was published in the Lancet<|>7\")  \n##  \n(\"relationship\"<|>ACTION TRIAL<|>J HYPERTENS<|>The trial's findings were published in the Journal of Hypertension<|>6\")  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_f7d73ccba9e22e6607bb18eb5842ec51fd675b37129bc2e9f4ce99c1a959e50a_v2"}